Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Conway

Showing results (411-420 of 711) with videos related to

Pageof 72
Sort By:
Journal of Wound Care|August 11, 2017
Cold atmospheric pressure plasma for treatment of chronic wounds: drug or medical device?A Kramer, B R Conway, K Meissner, et al.
International Journal of Clinical Practice|September 8, 2022
Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle EastReema A Karasneh, Basheer Y Khassawneh, Sayer Al-Azzam, et al.
Vaccines|October 26, 2021
Exploration of the Experience of Care Home Managers of COVID-19 Vaccination Programme Implementation and Uptake by Residents and Staff in Care Homes in Northern IrelandLinda Craig, Radi Haloub, Heather Reid, et al.
Journal of Vision|July 17, 2014
Color-detection thresholds in rhesus macaque monkeys and humansGalina Gagin, Kaitlin S Bohon, Adam Butensky, et al.
The Journal of Clinical Psychiatry|December 10, 2015
Clinical characteristics and management of treatment-resistant depressionCharles R Conway, Marie Anne Gebara, Marie C Walker, et al.
Journal of Psychiatric Research|June 25, 2024
Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2)Harold A Sackeim, Scott T Aaronson, Mark T Bunker, et al.
Psychological Medicine|January 5, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of lifeHarold A Sackeim, A John Rush, Teresa Greco, et al.
The Australian and New Zealand Journal of Psychiatry|May 11, 2021
The 'difficult-to-treat depression' and the 'response paradigm' models: Implications and relevance to patient managementR H McAllister-Williams, S T Aaronson, C R Conway, et al.
Bioorganic & Medicinal Chemistry|May 26, 2004
Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3beta (GSK-3beta) inhibitorsDavid J O'Neill, Lan Shen, Catherine Prouty, et al.
Journal of the American Society of Nephrology : JASN|October 26, 2013
MicroRNA-214 antagonism protects against renal fibrosisLaura Denby, Vasudev Ramdas, Ruifang Lu, et al.
Pageof 72

Showing results (411-420 of 711) with videos related to

Sort By:
Pageof 72
Journal of Wound Care|August 11, 2017
Cold atmospheric pressure plasma for treatment of chronic wounds: drug or medical device?A Kramer, B R Conway, K Meissner, et al.
International Journal of Clinical Practice|September 8, 2022
Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle EastReema A Karasneh, Basheer Y Khassawneh, Sayer Al-Azzam, et al.
Vaccines|October 26, 2021
Exploration of the Experience of Care Home Managers of COVID-19 Vaccination Programme Implementation and Uptake by Residents and Staff in Care Homes in Northern IrelandLinda Craig, Radi Haloub, Heather Reid, et al.
Journal of Vision|July 17, 2014
Color-detection thresholds in rhesus macaque monkeys and humansGalina Gagin, Kaitlin S Bohon, Adam Butensky, et al.
The Journal of Clinical Psychiatry|December 10, 2015
Clinical characteristics and management of treatment-resistant depressionCharles R Conway, Marie Anne Gebara, Marie C Walker, et al.
Journal of Psychiatric Research|June 25, 2024
Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2)Harold A Sackeim, Scott T Aaronson, Mark T Bunker, et al.
Psychological Medicine|January 5, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of lifeHarold A Sackeim, A John Rush, Teresa Greco, et al.
The Australian and New Zealand Journal of Psychiatry|May 11, 2021
The 'difficult-to-treat depression' and the 'response paradigm' models: Implications and relevance to patient managementR H McAllister-Williams, S T Aaronson, C R Conway, et al.
Bioorganic & Medicinal Chemistry|May 26, 2004
Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3beta (GSK-3beta) inhibitorsDavid J O'Neill, Lan Shen, Catherine Prouty, et al.
Journal of the American Society of Nephrology : JASN|October 26, 2013
MicroRNA-214 antagonism protects against renal fibrosisLaura Denby, Vasudev Ramdas, Ruifang Lu, et al.
Pageof 72